Who we are
Evidinno is a research consulting firm headquartered in Vancouver, Canada, with a global reach, delivering high-impact, evidence-based solutions worldwide.
Our team is composed of seasoned epidemiologists, biostatisticians, health economists, medical research scientists, and computer scientists, offering deep expertise in HEOR, regulatory affairs, and market access.
What we do
Our customized solutions and expert guidance help clients tackle complex research challenges and make informed strategic decisions.
We offer comprehensive literature reviews, advanced data analyses, bespoke evidence-generation strategies, economic modeling, medical writing, publication planning, and full-spectrum research consulting.
UBC Acquires Evidinno Outcomes Research, Expanding Real-World Evidence and HEOR Capabilities
United BioSource LLC (UBC) has acquired Evidinno Outcomes Research Inc., a Vancouver-based healthcare research consulting firm specializing in real-world evidence (RWE), epidemiology, evidence synthesis, and advanced statistical and economic analysis.
The acquisition strengthens UBC’s leadership in evidence generation offerings with globally recognized expertise in HEOR, medical affairs and market access.
King of Prussia, PA – 05 January 2025 | United BioSource LLC (UBC) today announced it has acquired Evidinno Outcomes Research Inc. (Evidinno), a healthcare research consulting firm headquartered in Vancouver, Canada specializing in real-world evidence (RWE), epidemiology, evidence synthesis, and advanced statistical & economic analysis.
UBC partners with biopharma to modernize evidence development and patient access pathways, ensuring therapies are safe, effective, and available to those who need them. The UBC full service late stage and post approval research offering leverages data acquisition technology embedded into modernized study designs and execution for the optimization of safety and value demonstration.
Evidinno’s team of seasoned epidemiologists, health economists, and research scientists, delivers market leading HTA and regulatory-grade evidence synthesis and health economic solutions. These offerings include AI-enabled, expert-led literature reviews, comparative effectiveness research, network meta-analyses, health economic modeling, HTA dossier development and research consulting across the product lifecycle.
“Evidinno’s scientific rigor and technology enabled workflows deepen our ability to curate fit-for-purpose evidence and health economic and outcomes insights for our clients. Together, we will transform the evidence value chain and help sponsors answer important questions on the safety and effectiveness of treatments for patients,” said Aaron Berger, SVP Evidence Development Solutions, UBC.
“Joining UBC marks an important step in expanding the reach and influence of Evidinno’s scientific and methodological expertise,” said Dr. Mir Sohail Fazeli, MD, PhD, Chief Executive Officer of Evidinno. “By combining our HTA- and regulatory-grade evidence synthesis solutions, real-world research, and economic modeling capabilities with UBC’s global platform, we are well positioned to deliver robust, decision-ready evidence that supports sponsors and improves outcomes for patients world-wide.”
Evidinno will operate as a wholly owned subsidiary of UBC with an integrated combined offering that enhances UBC’s ability to deliver full spectrum consulting and decision driving evidence across the clinical development and post approval continuum.
Fairmount Partners acted as exclusive financial advisor to Evidinno.
About UBC
UBC is a leading provider of Evidence Generation Solutions – specializing in real-world evidence, late-stage research, and robust technology infrastructure to support all therapies from development through post-approval. UBC’s customized solutions leverage unrivaled expertise, real-world data, and the latest technologies to demonstrate long-term product value and support better patient outcomes.
About Evidinno
Evidinno Outcomes Research Inc. is a global leader in evidence navigation and synthesis, offering strategic consulting, evidence generation, statistical and economic analysis, and medical writing services. With a multidisciplinary team and a strong track record of scientific contributions, Evidinno supports clients across the drug development continuum.
For more information, please contact:
Natania Barron, Head of Marketing | Natania.barron@ubc.com
What Our Clients Say About Us
Our Services
Strategic Consulting
Literature Reviews
Complex Statistical & Economic Analysis
Medical Writing and Publications
AI-Powered Solutions
Service Commitment
Evidinno strives for up-to-date, reproducible scientific methodology and complete client satisfaction. We pride ourselves for our keen eye for detail and dedication to excellence. We are committed to ensuring that all products and services delivered by Evidinno will be of the highest possible quality and presented in a timely manner.
To ensure client satisfaction, we value communication as one of the most important aspects of our business model and encourage our clients to be engaged and informed during the life-cycle of each project. We have engrained several stages of weekly or bi-weekly meetings throughout our production process to allow for comments, questions, and feedback from clients.
Direct client feedback is greatly valued at Evidinno. Each comment acts as a measure of our quality of service, can help refine our tailored approach to each client, and helps to ensure our commitment towards excellence. Additionally, our small business structure allows us to pass all deliverables through our highest ranked scientists, who carefully review and approve each deliverable and participate in all client meetings by providing direct consulting to clients daily.
Diversity and Inclusion
At Evidinno, we support a team of empowered, hard-working individuals, each bringing their own creative flare and unique experiences. Just as nature supports strength in biodiversity, we believe that a diverse team allows us to support a greater representation of human brilliance, draw insight from many perspectives, and foster the creativity and innovation required to give Evidinno a competitive advantage in the market. We are proud to state that Evidinno is a bona fide Aboriginal or minority business enterprise as defined and certified by the Canadian Aboriginal and Minority Supplier Council. Additionally, as a measure of our achievement of inclusion, over 70% of our employees are recognized as a visible minority in Canada and the US.
